|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.20 EUR | -0.76% |
|
-1.50% | -5.76% |
| 05-29 | HAEMATO AG announces Annual dividend, payable on July 10, 2026 | CI |
| 01-31 | PHOENIX Pharmahandel SE completed the acquisition of HAEMATO Pharm GmbH from HAEMATO AG. | CI |
| Market Cap | 66.91M 76.53M 61.76M 56.89M 107M 7.37B 110M 738M 290M 3.61B 287M 281M 12.43B | P/E 2023 * |
-
| P/E 2024 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 66.91M 76.53M 61.76M 56.89M 107M 7.37B 110M 738M 290M 3.61B 287M 281M 12.43B | EV / Sales 2023 * |
-
| EV / Sales 2024 * | - |
| Free-Float |
99.67% | Yield 2023 * |
-
| Yield 2024 * | - |
| 1 day | -0.76% |
| Manager | Title | Age | Since |
|---|---|---|---|
Patrick Brenske
CEO | Chief Executive Officer | - | 30/11/2020 |
Attila Strauss
PRN | Corporate Officer/Principal | - | 01/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrea Grosse
CHM | Chairman | 61 | 30/05/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.76% | -1.50% | - | - | 76.57M | |
| -0.10% | +3.21% | +56.40% | +20.77% | 315B | |
| -1.20% | -2.43% | +22.19% | -8.40% | 67.81B | |
| +0.35% | +2.11% | +34.61% | +93.22% | 9.23B | |
| +0.34% | +0.51% | +4.67% | +0.09% | 8.56B | |
| +1.53% | -3.64% | -22.99% | +3.93% | 4.18B | |
| -11.03% | -12.07% | -5.25% | +15.98% | 3.59B | |
| +1.87% | +3.36% | -47.86% | +27.51% | 3.55B | |
| -0.35% | -0.87% | +43.02% | +63.23% | 2.79B | |
| -7.41% | -2.37% | +3.82% | -22.47% | 2.09B | |
| Average | -1.68% | -1.72% | +9.84% | +21.54% | 46.3B | |
| Weighted average by Cap. | -0.36% | +1.02% | +46.72% | +17.12% |
| 2023 * | 2024 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- HAEK Stock
- HAE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
